Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1975 1
1993 1
1994 2
1995 2
1997 1
1998 2
1999 1
2002 1
2003 2
2005 1
2006 3
2007 1
2008 2
2009 1
2010 4
2011 8
2012 9
2013 5
2014 7
2015 8
2016 9
2017 10
2018 6
2019 7
2020 6
2021 7
2022 4
2023 3
2024 4
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

109 results

Results by year

Filters applied: . Clear all
Page 1
Maintenance therapy with dolutegravir and lamivudine versus bictegravir, emtricitabine, and tenofovir alafenamide in people with HIV (PASO-DOBLE): 48-week results from a randomised, multicentre, open-label, non-inferiority trial.
Ryan P, Blanco JL, Masia M, Garcia-Fraile L, Crusells MJ, Domingo P, Curran A, Guerri-Fernandez R, Bernal E, Bravo J, Revollo B, Macias J, Tiraboschi JM, Montejano R, Amador C, Torralba M, Merino D, Diaz-Brito V, Galindo MJ, Ferra S, Villoslada A, Losa JE, Fanjul FJ, Perez-Stachowski X, Peraire J, Portilla J, de la Fuente S, Dueñas C, Vazquez MJ, Di Gregorio S, Esteban H, Gil P, de Miguel M, Alejos B, Martínez E; PASO-DOBLE study group. Ryan P, et al. Among authors: losa je. Lancet HIV. 2025 Jul;12(7):e473-e484. doi: 10.1016/S2352-3018(25)00105-5. Epub 2025 Jun 7. Lancet HIV. 2025. PMID: 40489982 Clinical Trial.
[Emerging infectious diseases: a medical reality].
Losa JE. Losa JE. An Sist Sanit Navar. 2021 Aug 19;44(2):147-151. doi: 10.23938/ASSN.0968. An Sist Sanit Navar. 2021. PMID: 34427282 Free PMC article. Spanish. No abstract available.
Biomarkers for sepsis.
Henriquez-Camacho C, Losa J. Henriquez-Camacho C, et al. Among authors: losa j. Biomed Res Int. 2014;2014:547818. doi: 10.1155/2014/547818. Epub 2014 Mar 30. Biomed Res Int. 2014. PMID: 24800240 Free PMC article. Review.
Perspective: a stirring role for metabolism in cells.
Losa J, Leupold S, Alonso-Martinez D, Vainikka P, Thallmair S, Tych KM, Marrink SJ, Heinemann M. Losa J, et al. Mol Syst Biol. 2022 Apr;18(4):e10822. doi: 10.15252/msb.202110822. Mol Syst Biol. 2022. PMID: 35362256 Free PMC article. Review.
Screening for human immunodeficiency virus.
Henriquez Camacho C, Losa JE, Pérez Molina J, Villafuerte P. Henriquez Camacho C, et al. Among authors: losa je. Enferm Infecc Microbiol Clin (Engl Ed). 2018 Apr;36(4):256. doi: 10.1016/j.eimc.2017.09.003. Epub 2017 Nov 7. Enferm Infecc Microbiol Clin (Engl Ed). 2018. PMID: 29126569 English, Spanish. No abstract available.
Epidemiological trends of HIV/HCV coinfection in Spain, 2015-2019.
Fanciulli C, Berenguer J, Busca C, Vivancos MJ, Téllez MJ, Domínguez L, Domingo P, Navarro J, Santos J, Iribarren JA, Morano L, Artero A, Moreno J, Rivero-Román A, Santos I, Giner L, Armiñanzas C, Montero M, Manzardo C, Cifuentes C, García C, Galindo MJ, Ferrero OL, Sanz J, de la Fuente B, Rodríguez C, Gaspar G, Pérez L, Losa JE, Force L, Veloso S, Martínez-Alfaro E, Jarrín I, De Miguel M, González Garcia J; GeSIDA 8514 Study Group. Fanciulli C, et al. Among authors: losa je. HIV Med. 2022 Aug;23(7):705-716. doi: 10.1111/hiv.13229. Epub 2022 Jan 17. HIV Med. 2022. PMID: 35037379 Free PMC article.
Granular-cell tumours: an immunohistochemical study.
Junquera LM, de Vicente JC, Vega JA, Losa JL, Albertos JM, López-Arranz JS. Junquera LM, et al. Among authors: losa jl. Br J Oral Maxillofac Surg. 1997 Jun;35(3):180-4. doi: 10.1016/s0266-4356(97)90560-x. Br J Oral Maxillofac Surg. 1997. PMID: 9212295
Integrase inhibitors in children and adolescents: clinical use and resistance.
Torres-Fernandez D, Jiménez de Ory S, Fortuny C, Sainz T, Falcón D, Bernal E, Jiménez MC, Vilasaró MN, Epalza C, Navarro M, Ramos JT, Holguín Á, Prieto L; CoRIS and CoRISpe Spanish National Cohorts, CoRISpe and CoRISpe-FARO Cohort Working Group. Torres-Fernandez D, et al. J Antimicrob Chemother. 2022 Sep 30;77(10):2784-2792. doi: 10.1093/jac/dkac259. J Antimicrob Chemother. 2022. PMID: 35971971
109 results